Celsius Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2018-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.celsiustx.com
First-in-human, Single Ascending Dose Study of CEL383 in Healthy Adult Subjects
- First Posted Date
- 2023-06-13
- Last Posted Date
- 2024-02-09
- Lead Sponsor
- Celsius Therapeutics, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT05901883
- Locations
- 🇺🇸
Celerion, Lincoln, Nebraska, United States
© Copyright 2025. All Rights Reserved by MedPath